Klonopin: Package Insert and Label Information (Page 5 of 5)
PRINCIPAL DISPLAY PANEL — 0.5 mg Tablet Bottle Label
NDC 61269-605-10
Klonopin®
(clonazepam)
CIV
0.5 mg
Each tablet contains 0.5 mg clonazepam.
ATTENTION PHARMACIST: Dispense the
accompanying Medication Guide to each patient.
For additional Medication Guides visitwww.h2-pharma.com/products/klonopin/medicationguide.
100 tablets
Rx only
CHEPLAPHARM Arzneimittel
PRINCIPAL DISPLAY PANEL — 1 mg Tablet Bottle Label
NDC 61269-610-10
Klonopin®
(clonazepam)
CIV
1 mg
Each tablet contains 1 mg clonazepam.
ATTENTION PHARMACIST: Dispense the
accompanying Medication Guide to each patient.
For additional Medication Guides visitwww.h2-pharma.com/products/klonopin/medicationguide.
100 tablets
Rx only
CHEPLAPHARM Arzneimittel
PRINCIPAL DISPLAY PANEL — 2 mg Tablet Bottle Label
NDC 61269-620-10
Klonopin®
(clonazepam)
CIV
2 mg
Each tablet contains 2 mg clonazepam.
ATTENTION PHARMACIST: Dispense the
accompanying Medication Guide to each patient.
For additional Medication Guides visitwww.h2-pharma.com/products/klonopin/medicationguide.
100 tablets
Rx only
CHEPLAPHARM Arzneimittel
KLONOPIN clonazepam tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
KLONOPIN clonazepam tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
KLONOPIN clonazepam tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
Labeler — H2-Pharma, LLC (028473634) |
Registrant — CHEPLAPHARM Arzneimittel GmbH (329834878) |
Revised: 01/2023 H2-Pharma, LLC
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.